The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting the p300/CBP interactome through blockage of the CH1-domain triggers tumor regression in AR-positive and AR-negative xenograft models of castration-resistant prostate cancer (CRPC).
 
Valentino Cattori
Employment - Inthera Bioscience
Leadership - Inthera Bioscience
Stock and Other Ownership Interests - Inthera Bioscience
Patents, Royalties, Other Intellectual Property - Intarcia Therapeutics
 
Bernd Hentsch
Employment - Inthera Bioscience
Leadership - Inthera Bioscience
Stock and Other Ownership Interests - Inthera Bioscience
Consulting or Advisory Role - Inthera Bioscience
Patents, Royalties, Other Intellectual Property - 4SC; G2M Cncer Dugs AG
 
Ulrich Kessler
Employment - Inthera Bioscience
Leadership - Inthera Bioscience
Stock and Other Ownership Interests - Inthera Bioscience
Patents, Royalties, Other Intellectual Property - Intarcia Therapeutics